Suppr超能文献

miR-92a 通过靶向细胞外基质蛋白 1 的 3'UTR 区域拮抗其在 GC 转移中的促进作用。

MiR-92a antagonized the facilitation effect of extracellular matrix protein 1 in GC metastasis through targeting its 3'UTR region.

机构信息

School of Medicine, Shandong University, Jinan, 250012, China; Department of Geriatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230036, China; Anhui Provincial Key Laboratory of Tumour Immunotherapy and Nutrition Therapy, Hefei, 230001, China.

Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.

出版信息

Food Chem Toxicol. 2019 Nov;133:110779. doi: 10.1016/j.fct.2019.110779. Epub 2019 Aug 28.

Abstract

MicroRNAs were known to play very important roles in human diseases, and have attracted great interests of research scientists in medicine, toxicology and functional foods. Gastric carcinoma (GC) remains one of the most common and lethal types of malignancy worldwide. However, the molecular mechanism of GC and the role of microRNAs in GC development remain unclear. The expression of extracellular matrix protein 1 (ECM1) is up-regulated in many cancer types, but its functional role is inconstant. In the present study, we aimed to investigate the correlation between GC development and ECM1 expression, along with its regulation by microRNAs. Immunohistochemical results showed that ECM1 was up-regulated in GC tissues and ECM1 expression level was negatively correlated with the prognosis of GC. ECM1 was found to promote gastric cancer cell metastasis in cell migration assays by facilitating the expression of proteins involved in epithelial-mesenchymal transition (EMT). MiR-92a was recognized for the first time to suppress the migration of human GC cells by directly targeting to the 3'UTR of ECM1 gene in a dual-luciferase reporter assay. These results highlighted the antagonistic roles of ECM1 and miR-92a in GC development, which may serve as a new target for gastric cancer.

摘要

微小 RNA 被认为在人类疾病中发挥着非常重要的作用,引起了医学、毒理学和功能性食品研究科学家的极大兴趣。胃癌 (GC) 仍然是全球最常见和最致命的恶性肿瘤之一。然而,GC 的分子机制和 microRNAs 在 GC 发展中的作用仍不清楚。细胞外基质蛋白 1 (ECM1) 的表达在许多癌症类型中上调,但它的功能作用并不稳定。在本研究中,我们旨在研究 GC 发展与 ECM1 表达之间的相关性,以及 microRNAs 对其的调控。免疫组织化学结果表明,ECM1 在 GC 组织中上调,并且 ECM1 表达水平与 GC 的预后呈负相关。通过促进参与上皮-间充质转化 (EMT) 的蛋白质的表达,发现 ECM1 在细胞迁移实验中促进胃癌细胞的迁移。MiR-92a 被首次发现通过直接靶向 ECM1 基因的 3'UTR 在双荧光素酶报告基因实验中抑制人 GC 细胞的迁移。这些结果强调了 ECM1 和 miR-92a 在 GC 发展中的拮抗作用,可为胃癌提供新的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验